BIO-TECHNE Corp Revenue by Geography
No Revenue by Geography for TECH on this site yet.
- 2026-06-30: United States $635.37M; EMEA, excluding UK $294.22M; China $104.06M; APAC, excluding Greater China $85.81M.
- 2025-06-30: United States $683.23M; EMEA, excluding UK $266.31M; China $100.46M; APAC, excluding Greater China $77.26M.
- 2024-06-30: United States $657.75M; EMEA, excluding UK $241.43M; China $99.47M; APAC, excluding Greater China $73.90M.
- 2023-06-30: .
Source checked: the stored Revenue by Geography page for TECH.
Revenue by region
Each year (12 month)
| Fiscal year end | United States | EMEA, excluding UK | China | APAC, excluding Greater China | United Kingdom | Rest of World | Others | Total revenue |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $635.37M 52.29% | $294.22M 24.22% | $104.06M 8.56% | $85.81M 7.06% | $56.28M 4.63% | $39.28M 3.23% | $1.22B | |
| 2025-06-30 | $683.23M 56.02% | $266.31M 21.83% | $100.46M 8.24% | $77.26M 6.33% | $54.83M 4.50% | $37.55M 3.08% | $1.22B | |
| 2024-06-30 | $657.75M 56.75% | $241.43M 20.83% | $99.47M 8.58% | $73.90M 6.38% | $50.01M 4.31% | $36.50M 3.15% | $1.16B | |
| 2023-06-30 | Not split by region in the filing $1.14B 100.00% | $1.14B | ||||||
| 2022-06-30 | Not split by region in the filing $1.11B 100.00% | $1.11B | ||||||
| 2021-06-30 | Not split by region in the filing $931.03M 100.00% | $931.03M | ||||||
| 2020-06-30 | Not split by region in the filing $738.69M 100.00% | $738.69M | ||||||
| 2019-06-30 | Not split by region in the filing $714.01M 100.00% | $714.01M | ||||||
| 2018-06-30 | Not split by region in the filing $642.99M 100.00% | $642.99M | ||||||
| 2017-06-30 | Not split by region in the filing $563.00M 100.00% | $563.00M | ||||||
| 2016-06-30 | Not split by region in the filing $499.02M 100.00% | $499.02M | ||||||
| 2015-06-30 | Not split by region in the filing $452.25M 100.00% | $452.25M | ||||||
| 2014-06-30 | Not split by region in the filing $357.76M 100.00% | $357.76M | ||||||
| 2013-06-30 | Not split by region in the filing $310.57M 100.00% | $310.57M | ||||||
| 2012-06-30 | Not split by region in the filing $314.56M 100.00% | $314.56M | ||||||
| 2011-06-30 | Not split by region in the filing $289.96M 100.00% | $289.96M | ||||||
| 2010-06-30 | Not split by region in the filing $269.05M 100.00% | $269.05M | ||||||
| 2009-06-30 | Not split by region in the filing $263.96M 100.00% | $263.96M |
Each quarter (3 month)
| Quarter end | Others | Total revenue |
|---|---|---|
| 2026-06-30 | Not split by region $321.19M 100.00% | $321.19M |
| 2026-03-31 | Not split by region $311.42M 100.00% | $311.42M |
| 2025-12-31 | Not split by region $295.88M 100.00% | $295.88M |
| 2025-09-30 | Not split by region $286.56M 100.00% | $286.56M |
| 2025-06-30 | Not split by region $316.96M 100.00% | $316.96M |
| 2025-03-31 | Not split by region $316.18M 100.00% | $316.18M |
| 2024-12-31 | Not split by region $297.03M 100.00% | $297.03M |
| 2024-09-30 | Not split by region $289.46M 100.00% | $289.46M |
| 2024-06-30 | Not split by region $306.10M 100.00% | $306.10M |
| 2024-03-31 | Not split by region $303.43M 100.00% | $303.43M |
| 2023-12-31 | Not split by region $272.60M 100.00% | $272.60M |
| 2023-09-30 | Not split by region $276.94M 100.00% | $276.94M |
| 2023-06-30 | Not split by region $301.32M 100.00% | $301.32M |
| 2023-03-31 | Not split by region $294.15M 100.00% | $294.15M |
| 2022-12-31 | Not split by region $271.58M 100.00% | $271.58M |
| 2022-09-30 | Not split by region $269.65M 100.00% | $269.65M |
| 2022-06-30 | Not split by region $288.23M 100.00% | $288.23M |
| 2022-03-31 | Not split by region $290.38M 100.00% | $290.38M |
| 2021-12-31 | Not split by region $269.28M 100.00% | $269.28M |
| 2021-09-30 | Not split by region $257.72M 100.00% | $257.72M |
| 2021-06-30 | Not split by region $259.03M 100.00% | $259.03M |
| 2021-03-31 | Not split by region $243.55M 100.00% | $243.55M |
| 2020-12-31 | Not split by region $224.25M 100.00% | $224.25M |
| 2020-09-30 | Not split by region $204.20M 100.00% | $204.20M |
| 2020-06-30 | Not split by region $175.83M 100.00% | $175.83M |
| 2020-03-31 | Not split by region $194.68M 100.00% | $194.68M |
| 2019-12-31 | Not split by region $184.93M 100.00% | $184.93M |
| 2019-09-30 | Not split by region $183.24M 100.00% | $183.24M |
| 2019-06-30 | Not split by region $191.66M 100.00% | $191.66M |
| 2019-03-31 | Not split by region $184.86M 100.00% | $184.86M |
| 2018-12-31 | Not split by region $174.51M 100.00% | $174.51M |
| 2018-09-30 | Not split by region $162.97M 100.00% | $162.97M |
| 2018-06-30 | Not split by region $180.25M 100.00% | $180.25M |
| 2018-03-31 | Not split by region $163.97M 100.00% | $163.97M |
| 2017-12-31 | Not split by region $154.15M 100.00% | $154.15M |
| 2017-09-30 | Not split by region $144.61M 100.00% | $144.61M |
| 2017-06-30 | Not split by region $156.58M 100.00% | $156.58M |
| 2017-03-31 | Not split by region $144.04M 100.00% | $144.04M |
| 2016-12-31 | Not split by region $131.81M 100.00% | $131.81M |
| 2016-09-30 | Not split by region $130.58M 100.00% | $130.58M |
| 2016-06-30 | Not split by region $134.76M 100.00% | $134.76M |
| 2016-03-31 | Not split by region $130.97M 100.00% | $130.97M |
| 2015-12-31 | Not split by region $120.91M 100.00% | $120.91M |
| 2015-09-30 | Not split by region $112.38M 100.00% | $112.38M |
| 2015-06-30 | Not split by region $117.66M 100.00% | $117.66M |
| 2015-03-31 | Not split by region $114.16M 100.00% | $114.16M |
| 2014-12-31 | Not split by region $111.95M 100.00% | $111.95M |
| 2014-09-30 | Not split by region $108.48M 100.00% | $108.48M |
| 2014-06-30 | Not split by region $92.52M 100.00% | $92.52M |
| 2014-03-31 | Not split by region $95.56M 100.00% | $95.56M |
| 2013-12-31 | Not split by region $84.02M 100.00% | $84.02M |
| 2013-09-30 | Not split by region $85.67M 100.00% | $85.67M |
| 2013-06-30 | Not split by region $79.47M 100.00% | $79.47M |
| 2013-03-31 | Not split by region $80.99M 100.00% | $80.99M |
| 2012-12-31 | Not split by region $75.08M 100.00% | $75.08M |
| 2012-09-30 | Not split by region $75.03M 100.00% | $75.03M |
| 2012-06-30 | Not split by region $78.68M 100.00% | $78.68M |
| 2012-03-31 | Not split by region $83.62M 100.00% | $83.62M |
| 2011-12-31 | Not split by region $74.66M 100.00% | $74.66M |
| 2011-09-30 | Not split by region $77.60M 100.00% | $77.60M |
| 2011-06-30 | Not split by region $78.04M 100.00% | $78.04M |
| 2011-03-31 | Not split by region $76.27M 100.00% | $76.27M |
| 2010-12-31 | Not split by region $67.71M 100.00% | $67.71M |
| 2010-09-30 | Not split by region $67.94M 100.00% | $67.94M |
| 2010-06-30 | Not split by region $66.71M 100.00% | $66.71M |
| 2010-03-31 | Not split by region $70.28M 100.00% | $70.28M |
| 2009-12-31 | Not split by region $65.52M 100.00% | $65.52M |
| 2009-09-30 | Not split by region $66.53M 100.00% | $66.53M |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |